Gradient Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-113	Closed	-$27.5K	–	331
2024 Q2	$27.5K	Buy	113 +1	+0.9%	+$158	﹤0.01%	587
2024 Q1	$16.7K	Sell	112 -2	-2%	-$334	﹤0.01%	577
2023 Q4	$21.8K	Hold	114	–	–	﹤0.01%	691
2023 Q3	$20.2K	Sell	114 -2	-2%	-$382	﹤0.01%	679
2023 Q2	$22K	Buy	116 +6	+5%	+$1.19K	﹤0.01%	670
2023 Q1	$22K	Sell	110 -1	-0.9%	-$210	﹤0.01%	663
2022 Q4	$26.4K	Buy	111 +1	+0.9%	+$213	﹤0.01%	634
2022 Q3	$22K	Hold	110	–	–	﹤0.01%	646
2022 Q2	$16K	Hold	110	–	–	﹤0.01%	680
2022 Q1	$18K	Hold	110	–	–	﹤0.01%	663
2021 Q4	$19K	Hold	110	–	–	﹤0.01%	669
2021 Q3	$21K	Hold	110	–	–	﹤0.01%	629
2021 Q2	$19K	Hold	110	–	–	﹤0.01%	644
2021 Q1	$16K	Hold	110	–	–	﹤0.01%	657
2020 Q4	$16K	Hold	110	–	–	﹤0.01%	607
2020 Q3	$16K	Hold	110	–	–	﹤0.01%	611
2020 Q2	$16K	Hold	110	–	–	﹤0.01%	562
2020 Q1	$12K	Hold	110	–	–	﹤0.01%	606
2019 Q4	$13K	Hold	110	–	–	﹤0.01%	634
2019 Q3	$9K	Hold	110	–	–	﹤0.01%	678
2019 Q2	$8K	Buy	+110	New	+$8.44K	﹤0.01%	695